Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Endothelial dysfunction and inflammation: what is the link?

Jan Galle¹, Thomas Quaschning, Stefan Seibold

¹Department of Medicine, Division of Nephrology, Julius-Maximilians-University, Würzburg, Germany. J-C.Galle@mail.uni-wuerzburg.de

Kidney International. Supplement

|April 16, 2003

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Epicardial fat, cardiovascular risk factors and calcifications in patients with chronic kidney disease.

Clinical kidney journal·2020

Same author

Short-Term Changes in Albuminuria and Risk of Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EMPA-REG OUTCOME Trial.

Journal of the American Heart Association·2020

Same author

Funding kidney research as a public health priority: challenges and opportunities.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2020

Same author

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.

The New England journal of medicine·2020

Same author

Risk factors for retinopathy in hemodialysis patients with type 2 diabetes mellitus.

Scientific reports·2020

Same author

Predicting the Development of Anti-Drug Antibodies against Recombinant alpha-Galactosidase A in Male Patients with Classical Fabry Disease.

International journal of molecular sciences·2020

Cardiovascular disease in end-stage renal disease (ESRD) is linked to endothelial dysfunction. This study explores how inflammation and oxidative stress contribute to vascular damage and disease progression.

Area of Science:

Vascular Biology
Nephrology
Cardiology

Background:

Cardiovascular disease (CVD) is the leading cause of death in end-stage renal disease (ESRD) patients, often stemming from arteriosclerosis.
Endothelial dysfunction is an early indicator of arteriosclerosis, appearing in various vascular beds and potentially predicting CVD prognosis.

Purpose of the Study:

To investigate whether endothelial dysfunction is a marker or an active contributor to cardiovascular disease progression.
To highlight the interconnected roles of inflammation, endothelial dysfunction, and oxidative stress in arteriosclerosis.

Main Methods:

Review of existing literature on arteriosclerosis, endothelial dysfunction, and oxidative stress in ESRD.
Analysis of the mechanisms linking inflammation, oxidative stress, and vascular remodeling.

Related Experiment Videos

Main Results:

Inflammatory processes in arteriosclerosis increase reactive oxygen species (ROS) production, causing endothelial dysfunction.
Activated renin-angiotensin system and oxidized LDL contribute significantly to vascular oxidative stress.
The endothelium is both a target and a source of ROS, exacerbating oxidative stress.

Conclusions:

Endothelial dysfunction is intricately linked with inflammation and oxidative stress in the pathogenesis of cardiovascular disease in ESRD.
Oxidative stress, driven by inflammation and other factors, plays a crucial role in the progression of vascular damage.
Understanding this interplay is vital for developing targeted therapies for cardiovascular complications in ESRD.